Viona Pharmaceuticals Inc., Issues Voluntary Nationwide Recall of Metformin HCl Extended- Release Tablets, USP 750 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

Date: 01/12/2022

Product type: Drugs, Impurity

Company Announcement Date: January 07, 2022
FDA Publish Date: January 12, 2022
Product Type: Drugs
Reason for Announcement: N-Nitrosodimethylamine (NDMA) Impurity
Company Name: Viona Pharmaceuticals, Inc.
Brand Name: Viona
Product Description: Metformin Hydrochloride Extended-Release Tablets

USA-FDA Link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/viona-pharmaceuticals-inc-issues-voluntary-nationwide-recall-metformin-hcl-extended-release-tablets-0